Medulloblastoma and primitive neuroectodermal tumors.
Medulloblastomas and sPNETs remain highly problematic tumors to treat. Prognosis has improved over the past two decades, but many children who survive treatment have significant long-term sequelae. The improvements in outcome have been due to advances in surgical techniques, the wider use of chemotherapy, and the more judicious use of radiotherapy. For further improvements,the recent impressive discoveries concerning molecular mechanisms of embryonal tumor origin, development,and growth will need to be translated into molecularly based, risk-adapted therapy.
The George Washington University, Washington, DC, USA. rpacker@cnmc.org
Roger J
RJ
Packer
Tobey
T
Macdonald
Gilbert
G
Vezina
Robert
R
Keating
Mariarita
M
Santi
D001932:Brain Neoplasms / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D006801:Humans; D008527:Medulloblastoma / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D018242:Neuroectodermal Tumors, Primitive / Q000175:diagnosis / Q000453:epidemiology / Q000628:therapy; D059906:Neuroimaging